-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US1920051067-
CodexisBörse Börse FrankfurtEURSymbol 4QK
-
CodexisBörse Börse BerlinEURSymbol 4QK
-
CODEXIS INCBörse Börse DüsseldorfEURSymbol 4QK
-
CODEXIS INCBörse Gettex System der Börse MünchenEURSymbol 4QK
-
CODEXIS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 4QK
-
CODEXIS INCBörse Quotrix System der Börse DüsseldorfEURSymbol 4QK
-
CODEXIS INCBörse Börse StuttgartEURSymbol 4QK
-
CodexisBörse NasdaqISIN US1920051067 WKN: A0Q2S4USDSymbol CDXS
-
ISIN US1920051067 WKN: A0Q2S4USDSymbol CDXS
-
EURSymbol 4QK
-
Codexis, Inc.Börse London Stock Exchange
-
ISIN US1920051067
WKN A0Q2S4
Symbol CDXS
Währung
USD
Börse
Nasdaq Zeitzone: Europe/Berlin
Firmenname
Codexis, Inc
Marktkapitalisierung
1.488.230.464 (+- 12%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.672.460.928 oder 1.304.000.000
Mitarbeiter
205 (+- 21%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
161 oder 248 Mitarbeiter
EBITDA -13.167.000
PEGRatio -1.16
Buchwert 1.533
Codexis outperformed den DAX um +563 % vom 08.05.2014 bis 27.03.2020
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 17,2 EUR -7,52%
Portrait der Codexis Aktie
Das Unternehmen Codexis, Inc aus USA beschäftigt 205 Mitarbeiter.
Die Codexis Aktie konnte seit dem 08.05.2014 eine Rendite von sage und schreibe 566% erwirtschaften.
Das Unternehmen Codexis, Inc ist nur in 6 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Codexis mit 0,14% im ETF.
6 ETFs die in Codexis investieren
Dir gefallen die Informationen zu Codexis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Codexis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Codexis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Codexis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
30 News & Informationen zur Codexis Aktie
Codexis confirms receipt of ~$15M follow-on orders for proprietary enzyme (NASDAQ:CDXS)
Enzyme engineering company Codexis (CDXS) has confirmed the receipt of ~$15M follow-on orders for a proprietary high performance enzyme from an undisclosed global…
Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company
Orders Support Company’s Recently Increased 2021 Guidance…
Opaleye Management Inc. Buys Kiniksa Pharmaceuticals, Larimar Therapeutics Inc, CM Life Sciences Inc, Sells Autolus Therapeutics PLC, Gemini Therapeutics Inc, Checkpoint Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
Global Diagnostics Enzyme Market Report 2021: Nuclease Enzymes are Expected to Dominate the Diagnostic Enzyme Market – Forecast to 2026
/PRNewswire/ — The
Global Diagnostics Enzyme Market Report 2021: Nuclease Enzymes Are Expected To Dominate The Diagnostic Enzyme Market – Forecast To 2026
DUBLIN, Aug. 23, 2021 /PRNewswire/ — The “Diagnostics Enzyme Market – Growth, Trends, Covid-19 Impact and Forecasts (2021 – 2026)” report has been added to
Codexis Inc (CDXS) President and CEO John J Nicols Sold $1.7 million of Shares
GuruFocus Article or News written by insider and the topic is about:
Pier Capital, LLC Buys Everbridge Inc, RadNet Inc, Jamf Holding Corp, Sells Methode Electronics Inc, Redfin Corp, Diodes Inc
GuruFocus Article or News written by insider and the topic is about:
After Golden Cross, Codexis (CDXS)'s Technical Outlook is Bright
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Codexis, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:CDXS)
The following slide deck was published by Codexis, Inc.
Codexis, Inc. (CDXS) CEO John Nicols on Q2 2021 Results – Earnings Call Transcript
Codexis, Inc. (NASDAQ:CDXS) Q2 2021 Earnings Conference Call August 05, 2021, 16:30 ET Company Participants Stephanie Marks – Argot Partners John Nicols – President, CEO & Director Ross…
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of 58.82% and 41.06%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …
Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient
REDWOOD CITY, Calif. and KALAMAZOO, Mich., July 26, 2021 — Codexis, Inc. , a leading enzyme engineering company enabling the promise of synthetic biology, and Kalsec, Inc., a leading global… | July 26, 2021
Where Do Hedge Funds Stand On Guess’, Inc. (GES)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession…
Chiral Chemicals Market growth analysis in Diversified Chemical | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The chiral chemicals market is poised to grow by USD 5.89 billion during 2021-2025 progressing at a CAGR of almost 9% during the forecast…
Chiral Chemicals Market growth analysis in Diversified Chemical | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The chiral chemicals market is poised to grow by USD 5.89 billion during 2021-2025 progressing at a CAGR of almost 9% during the forecast…
Chiral Chemicals Market Growth Analysis In Diversified Chemical | Emerging Trends, Company Risk, And Key Executives | Technavio
NEW YORK, July 20, 2021 /PRNewswire/ — The chiral chemicals market is poised to grow by USD 5.89 billion during 2021-2025 progressing at a CAGR of almost 9%
Codexis Announces Completion Of CodeEvolver® License Technology Transfer With Global Pharmaceutical Leader
REDWOOD CITY, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic
Here is What Hedge Funds Think About Luminex Corporation (LMNX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
ARK Investment Leans Into Biotech and Telecom Holdings
GuruFocus Article or News written by Graham Griffin and the topic is about: Holdings grow alongside a new buy into a blank check company
Industry Executive Says Synthetic Biology Is the Next Silicon Valley
GuruFocus Article or News written by Barry Cohen and the topic is about: Leaders include Amyris, Precigen and Twist Bioscience
Codexis earns a ‘significant’ milestone payment from GlaxoSmithKline (NASDAQ:CDXS)
Codexis (CDXS) announced that it won a “significant” milestone payment from the U.K
Codexis Earns Milestone Payment from GlaxoSmithKline
REDWOOD CITY, Calif., July 07, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company enabling the promise of synthetic …
Global Phenylketonuria Treatment Market (2021 to 2026) – by Type, Route, End-user and Geography
DUBLIN, June 25, 2021 /PRNewswire/ — The 'Global Phenylketonuria Treatment Market (2021-2026) by Type, Route, End-user, Geography, Competitive An…
Strength Seen in Codexis (CDXS): Can Its 12.6% Jump Turn into More Strength?
Codexis (CDXS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Strength Seen in Codexis (CDXS): Can Its 12.6% Jump Turn into More Strength?
Stocks Analysis by Zacks Investment Research covering: Codexis Inc. Read Zacks Investment Research's latest article on Investing.com
Stocks That Hit 52-Week Highs On Friday
This morning 150 companies reached new 52-week highs.
Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm by market cap to set a new …
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …
Codexis Introduces Improved Enzymes To Further Enhance Tate & Lyle's Stevia And Allulose Production
REDWOOD CITY, Calif. and HOFFMANN ESTATES, Ill., Jan. 13, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and
Stocks That Hit 52-Week Highs On Friday
This morning 470 companies set new 52-week highs.
Facts of Interest: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a …